ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PTLA Portola Pharmaceuticals Inc

18.03
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Portola Pharmaceuticals Inc NASDAQ:PTLA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.03 18.00 18.10 0 01:00:00

PTLA LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of its Investigation into Portola Pharmaceuticals, Inc., and Enco...

27/01/2020 6:46pm

PR Newswire (US)


Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Portola Pharmaceuticals Charts.

NEW YORK, Jan. 27, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Portola Pharmaceuticals, Inc. ("Portola" or the "Company") (NASDAQ: PTLA) from allegations that Portola might have issued misleading information to the investing public.

Bernstein Liebhard LLP.  (PRNewsFoto/Bernstein Liebhard LLP) (PRNewsfoto/Bernstein Liebhard LLP)

If you purchased Portola securities, and/or would like to discuss your legal rights and options please visit Portola Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

On January 10, 2020 Portola announced that its preliminary fourth quarter revenue from its drug Andexxa, an antidote for patients treated with anticoagulants, would only be approximately $28 million which was well below the $39 million estimate and $41 million consensus. Portola attributed the performance in part to cost-cutting at hospitals noting that "hospital pharmacies curtailed use of Andexxa following drug utilization reviews in an effort to manage pharmacy budgets."

On this news, shares of Portola dropped precipitously during intra-day trading on January 10, 2020.

If you purchased Portola securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/portolapharmaceuticalsinc-ptla-shareholder-class-action-lawsuit-stock-fraud-239/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.  

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ptla-losses-alert-bernstein-liebhard-llp-reminds-investors-of-its-investigation-into-portola-pharmaceuticals-inc-and-encourages-investors-with-losses-to-contact-the-firm-300993681.html

SOURCE Bernstein Liebhard LLP

Copyright 2020 PR Newswire

1 Year Portola Pharmaceuticals Chart

1 Year Portola Pharmaceuticals Chart

1 Month Portola Pharmaceuticals Chart

1 Month Portola Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock